Related Experiment Videos
Chelation therapy. Unproved modality in the treatment of Alzheimer-type dementia
Insights
Despite advances in understanding Alzheimer's disease, effective treatments remain elusive. This study examines individuals with Alzheimer-type dementia who underwent unproven chelation therapy.
Area of Science:
- Neurology
- Geriatrics
- Pharmacology
Background:
- Alzheimer's disease is a leading cause of cognitive decline in the elderly.
- Current understanding of neuropathology and neurochemistry in Alzheimer's disease is advancing.
- No approved pharmacologic agents can halt or reverse Alzheimer's disease progression.
Observation:
- Physicians lack effective treatments for Alzheimer's disease.
- Unproven, costly, and potentially dangerous therapies like chelation are increasingly used.
- This paper describes individuals with Alzheimer-type dementia who received chelation therapy.
Findings:
- The study focuses on describing patient cases undergoing chelation therapy for Alzheimer's.
- Detailed findings on the outcomes of chelation therapy in these patients are presented.
Implications:
- Highlights the unmet need for effective Alzheimer's disease treatments.
- Raises concerns about the use of unproven therapies in dementia care.
- Underscores the importance of evidence-based medicine in managing Alzheimer's disease.
Abstract:
Despite a dramatic increase in the understanding of the neuropathologic and neurochemical alterations accompanying Alzheimer's disease, by far the largest cause of progressive and incapacitating cognitive dysfunction in the elderly, physicians have as yet no pharmacologic agent that can be prescribed safely either to arrest or reverse this decline. This lack of effective therapeutic agents is contributing to the use by an increasing number of health professionals, including physicians and concerned families, of unproved, costly, and potentially dangerous modalities, such as chelation therapy. The purpose of this paper is to describe some individuals with Alzheimer-type dementia who have undergone chelation therapy.